A 34-year-old Hispanic-American male with end-stage renal disease received kidney transplant from a cadaver donor, as no one in his family was a good match. His post-operative course was uneventful, and he was discharged with the antirejection drugs Tacrolimus (Prograf), Cyclosporine (Neoral), and Imuran (Azathioprine). He did well for 3 months and had returned to his job as a policeman. Six months after his transplant, he began to gain weight, had decreased urine output, was very fatigued, and began to run temperatures up to 101˚F. He was evaluated by his nephrologist, who diagnosed acute kidney transplant rejection.

Develop a 1- to 2-page case study analysis in which you:

  • Explain why you think the patient presented the symptoms described.
  • Identify the genes that may be associated with the development of the disease.
  • Explain the process of immunosuppression and the effect it has on body systems.

Expert Solution Preview


This case study analysis will focus on a 34-year-old Hispanic-American male who underwent a kidney transplant due to end-stage renal disease. Following the transplantation, the patient experienced a period of uneventful recovery but developed symptoms indicative of acute kidney transplant rejection six months later. The analysis will explore the potential reasons for these symptoms, the genes associated with the disease, and the impact of immunosuppression on the body systems.

1. Explanation of the Patient’s Symptoms:

The patient’s symptoms of weight gain, decreased urine output, fatigue, and elevated temperature can be attributed to acute kidney transplant rejection. Rejection occurs when the recipient’s immune system recognizes the transplanted organ as foreign and mounts an immune response against it.

During acute rejection, immune cells infiltrate the transplanted kidney and cause inflammation. This inflammatory response disrupts the normal functioning of the kidney, resulting in decreased urine output. Additionally, inflammation and tissue damage can lead to fluid retention, causing weight gain.

The systemic effects of inflammation, along with the physical and emotional stress of rejection, can contribute to the patient’s fatigue. The presence of fever suggests an ongoing immune response and inflammation in the transplanted kidney.

2. Genes Associated with the Development of the Disease:

Several genes have been identified as potential contributors to the development of acute kidney transplant rejection. Human leukocyte antigen (HLA) genes play a crucial role in the recognition of self and non-self antigens by the immune system. HLA genes help determine the compatibility between the donor and recipient, as a closer match reduces the risk of rejection.

Polymorphisms in specific HLA genes, such as HLA-DR and HLA-DQ, have been associated with an increased risk of acute rejection. These polymorphisms can affect the ability of the immune system to recognize transplanted tissue as self, leading to a heightened immune response.

3. Process of Immunosuppression and Its Effects on Body Systems:

Immunosuppression is an essential component of post-transplant management to prevent rejection. Medications such as Tacrolimus (Prograf), Cyclosporine (Neoral), and Imuran (Azathioprine) are commonly used for this purpose.

These medications target different aspects of the immune system to suppress its activity. Tacrolimus and Cyclosporine inhibit T-cell activation, an integral part of the immune response. By blocking T-cell activation, these drugs reduce the risk of rejection by dampening the immune response against the transplanted kidney.

Imuran (Azathioprine) is an immunosuppressant that interferes with DNA synthesis in rapidly dividing cells, including T and B lymphocytes. By inhibiting lymphocyte proliferation, Azathioprine minimizes the immune response.

While immunosuppression is vital for preventing rejection, it also weakens the overall immune system. This can increase the patient’s susceptibility to infections and result in adverse effects such as increased risk of malignancies, metabolic disturbances, and drug-related toxicities.


In conclusion, the presented case study illustrates a patient experiencing symptoms of acute kidney transplant rejection. The symptoms can be attributed to the immune response mounted by the patient against the transplanted kidney. Several genes, particularly HLA genes, may influence the development of acute rejection. Immunosuppression medication plays a crucial role in preventing rejection but also has systemic effects on the body, including increased susceptibility to infections and adverse drug reactions. Understanding the underlying mechanisms and genetic factors of transplant rejection aids in the management and personalized care of patients undergoing organ transplantation.